Please login to the form below

Not currently logged in
Email:
Password:

UK Market Access

This page shows the latest UK Market Access news and features for those working in and with pharma, biotech and healthcare.

Health secretary’s ‘rip off’ remarks anger UK pharma

Health secretary’s ‘rip off’ remarks anger UK pharma

Health secretary’ s ‘ rip off’ remarks anger UK pharma. Row with Vertex has tainted government-industry relations. ... stockpiling to ensure the same taxpayers are able to access life-saving medicines after Brexit.”.

Latest news

More from news
Approximately 18 fully matching, plus 47 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Of course, the loss is not solely confined to the UK, which provides substantial regulatory and market access expertise to the EU through the MHRA and NICE, as well as a ... Sciences Industrial Strategy and the Accelerated Access Review, leaving the UK

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    Marketing authorisations. With no access to the single market, UK pharmaceutical companies will be forced to make two separate regulatory submissions - one to the EU and one to the UK. ... This may well position the UK as a secondary or tertiary launch

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    Market access in Europe: balancing access and affordability. European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new ... The AAR speaks of 'win-win

  • Speaking the language of effective communications Speaking the language of effective communications

    Having previously co-founded and led ghg's UK-based market access consultancy The WG Group, Claire is now based in London and leading a ghg's executive team that operates ... That work encompasses advertising, medical education and strategy, in addition

  • Getting below the surface: regional and local market access Getting below the surface: regional and local market access

    In Germany, there are regional and local regulations in addition to the centralised market access regulations. ... Quintiles' expertise in market access, built up over many years and in many countries, is based on its network of experienced field-based

More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest appointments

  • RJW & Partners appoints new director RJW & Partners appoints new director

    She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access. ... Prior to that Beecher was with  Bristol-Myers Squibb, where she was UK pricing and market access manager, and before that

  • PM Society appoints new chairman PM Society appoints new chairman

    Bradley previously served as the PM Society's market access lead, and is brand manager for Shire's internal medicine business unit, making him the society's first chair from a ... He has since held a series of increasingly senior positions at Shire,

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland appoints market access director. Peter Wheatley Price brings experience from GSK, Janssen and Boehringer Ingelheim. ... He also brings experience form Boehringer Ingelheim, where he was director of its UK Change Project, head of UK

  • GalbraithWight appoints Eithne McShane and Steve Mazzarese GalbraithWight appoints Eithne McShane and Steve Mazzarese

    GalbraithWight appoints Eithne McShane and Steve Mazzarese. They join the market access consultancy as global business development directors. ... In her new role at UK-based market access consultancy she will be tasked with growing GalbraithWight's

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    The Association of the British Pharmaceutical Industry (ABPI) has appointed Richard Torbett as executive director - commercial UK. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Biosimilars: Getting the flock to market

    Biosimilars: Getting the flock to market. The biosimilars field is about to become very crowded. ... This was amplified by the UK’ s chief pharmaceutical officer, who stated that “ Biosimilar medicines have enormous potential to deliver increased

  • M&F Health

    Expertise:. Market access. UK programmes. International programmes. Consumer programmes. NHS consultancy. ... 2013 Ecellence in Communicationof Survey of Market Research (Highly Commended). 2010 Judge’ s Award for Innovation in Healthcare

  • Portcullis Public Affairs

    We help Government reach better decisions. Portcullis is in partnership with MAP BioPharma which helps clients navigate the detailed processes so as to achieve optimal market access in the UK, Ireland ... Together, we provide a unique combination of

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics